StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$0.80−0.11 (-12.07%)

Close on Nov 20, 2026Market cap $6.03MP/E –Yield –

BioVie shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioVie's shares outstanding was 8M at Jun 30, 2026. For fiscal 2026 it was 7M, up 390.5% from the year before. Over ten years it grew 26.4% a year on average. The highest annual figure on record is 25M in fiscal 2022.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 20267M+390.5%
FY2025Jun 30, 20251M+227.0%
FY2024Jun 30, 20240M-86.1%
FY2023Jun 30, 20233M-86.8%
FY2022Jun 30, 202225M+98.8%
FY2021Jun 30, 202112M+151.6%
FY2020Jun 30, 20205M+94.1%
FY2019Jun 30, 20193M+231.5%
FY2018Jun 30, 20181M+7.1%
FY2017Jun 30, 20171M+2.5%
FY2016Jun 30, 20161M-0.0%
FY2015Jun 30, 20151M+0.1%
FY2014Jun 30, 20141M+111.2%
FY2013Jun 30, 20130M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 20268M+326.4%
Q3 FY2026CQ1 2026Mar 31, 20268M+307.6%
Q2 FY2026CQ4 2025Dec 31, 20258M+404.0%
Q1 FY2026CQ3 2025Sep 30, 20255M+715.0%
Q4 FY2025CQ2 2025Jun 30, 20252M-58.5%
Q3 FY2025CQ1 2025Mar 31, 20252M-51.5%
Q2 FY2025CQ4 2024Dec 31, 20242M-57.2%
Q1 FY2025CQ3 2024Sep 30, 20241M-98.2%
Q3 FY2024CQ1 2024Mar 31, 20244M-85.6%
Q2 FY2024CQ4 2023Dec 31, 20234M-86.0%
Q1 FY2024CQ3 2023Sep 30, 20234M-85.3%
Q3 FY2023CQ1 2023Mar 31, 202335M+41.4%
Q2 FY2023CQ4 2022Dec 31, 202231M+24.9%
Q1 FY2023CQ3 2022Sep 30, 202227M+14.7%
Q4 FY2022CQ2 2022Jun 30, 202225M+58.1%
Q3 FY2022CQ1 2022Mar 31, 202225M+79.5%
Q2 FY2022CQ4 2021Dec 31, 202125M+79.4%
Q1 FY2022CQ3 2021Sep 30, 202124M+297.2%
Q4 FY2021CQ2 2021Jun 30, 202116M+204.0%
Q3 FY2021CQ1 2021Mar 31, 202114M+167.7%
Q2 FY2021CQ4 2020Dec 31, 202014M+168.5%
Q1 FY2021CQ3 2020Sep 30, 20206M+44.5%
Q4 FY2020CQ2 2020Jun 30, 20205M+95.0%
Q3 FY2020CQ1 2020Mar 31, 20205M+108.2%
Q2 FY2020CQ4 2019Dec 31, 20195M+561.3%
Q1 FY2020CQ3 2019Sep 30, 20194M+432.9%
Q4 FY2019CQ2 2019Jun 30, 20193M+251.4%
Q1 FY2019CQ3 2018Dec 31, 20182M+234.6%
Q4 FY2018CQ2 2018Jun 30, 20181M+6.8%
Q3 FY2018CQ1 2018Mar 31, 20181M+6.0%
Q2 FY2018CQ4 2017Dec 31, 20171M+8.4%
Q1 FY2018CQ3 2017Sep 30, 20171M+7.0%
Q4 FY2017CQ2 2017Jun 30, 20171M+5.3%
Q3 FY2017CQ1 2017Mar 31, 20171M–
Q2 FY2017CQ4 2016Dec 31, 20161M–
Q1 FY2017CQ3 2016Sep 30, 20161M–
Q4 FY2016CQ2 2016Jun 30, 20161M–

More BioVie figures

See a number that looks wrong?